AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 268 filers reported holding AVANOS MED INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,331 | -71.6% | 169,440 | -67.0% | 0.01% | -75.0% |
| Q1 2023 | $15,252 | +68.5% | 512,845 | +53.4% | 0.02% | +53.8% |
| Q4 2022 | $9,049 | -99.8% | 334,419 | +88.2% | 0.01% | +116.7% |
| Q3 2022 | $3,871,000 | +76.2% | 177,717 | +121.1% | 0.01% | +100.0% |
| Q2 2022 | $2,197,000 | -56.1% | 80,371 | -46.1% | 0.00% | -50.0% |
| Q1 2022 | $5,000,000 | -39.1% | 149,242 | -33.9% | 0.01% | -40.0% |
| Q2 2021 | $8,213,000 | -32.3% | 225,813 | -18.6% | 0.01% | -37.5% |
| Q1 2021 | $12,128,000 | +45.4% | 277,273 | +52.6% | 0.02% | +33.3% |
| Q4 2020 | $8,339,000 | +194.6% | 181,748 | +88.7% | 0.01% | +140.0% |
| Q2 2020 | $2,831,000 | +614.9% | 96,317 | +555.2% | 0.01% | +400.0% |
| Q1 2020 | $396,000 | – | 14,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |